• Conversa

  Participated · Series A · May 2017

  Conversa provides a scalable conversation platform that delivers smart, automated and personalized doctor–patient conversations across health experiences such as chronic condition management, post-discharge and medication adherence. The platform draws from more than 400 biometric devices plus clinical, claims and patient-generated data and can populate actionable data into a patient’s EHR or care management system. Conversa maintains an extensive library of over 50 clinically-intelligent conversation programs covering conditions like asthma, COPD, CHF, diabetes, hypertension and joint replacement. The company reports customer outcomes including a cited 20% reduction in costly post-acute care for joint replacement patients (about $3,400 savings per patient over 90 days) and over 80% of patients reporting higher engagement. Conversa has commercial partnerships and customers including Northwell, Ochsner Health System, Citrus Valley Health Partners and Centura Health’s Penrose St. Francis. The company is expanding product capabilities, its clinical conversation library, customer and distribution operations, and its team to meet growing market demand.

• Conversa Health

  Participated · Series A · May 2017

  Conversa Health provides an enterprise virtual care and communication platform that links providers’ EHRs and patient data to interactive digital care pathways and a clinical analytics engine to automate care management 24×7. Its platform and library of digital pathways are used by providers to manage patients across populations rather than one-off point solutions, improving pre- and post-visit care-plan adherence. During the COVID-19 pandemic the company’s customer count grew fourfold and its financial metrics increased sixfold as larger customers expanded use of the platform. Conversa is expanding its product to support vaccination programs for consumer education and post-vaccination monitoring. To capitalize on recent momentum the company plans to hire more engineers and scale the platform. Company leadership believes remote and automated care will remain in demand after the pandemic and anticipates significant growth in virtual care delivery. Conversa Health offers an automated, chat-based virtual care and communication platform that triages patients, gathers patient data, and integrates with connected devices. The company positions its platform as the digital front door for health systems, aiming to scale personalized engagement and care. Conversa has launched Employee HealthCheck to screen workers before they return to work and has additional programs to screen for mental health concerns. The platform is being used by providers to check patients and loved ones before facility visits and to manage COVID-related workflows. Northwell Health has used Conversa to scale communications and care for thousands of COVID-19 patients with programs focused on lab results, quarantine and antibody tests. The company characterizes itself as, in many ways, a data company. Conversa is a San Francisco-based healthcare conversation platform that aims to improve doctor–patient communication. Its Conversa Conversation Platform™ delivers smart, automated, patient-profile driven conversations across key health experiences including chronic condition management, post-discharge and pre- and post-surgery care, patient education, medication adherence, appointment scheduling and lifestyle coaching. The platform sources data from more than 400 biometric devices together with clinical, claims and patient-generated data to provide providers with real-time information for care adjustments and resource allocation. Conversa is being adopted by health systems such as Northwell, Ochsner Health System, Citrus Valley Health Partners and Centura Health’s Penrose St. Francis. Led by CEO and co-founder West Shell III, the company plans to use its newly raised capital to expand product capabilities, grow its clinical conversation library, enhance customer and distribution partner operations, and scale the team. Financially, Conversa secured $8M in Series A funding led by Northwell Ventures with participation from Epic Ventures, Healthgrades and existing investors. Conversa Health is a San Francisco, CA–based provider of patient relationship management services. Led by co-founder and CEO West Shell III and newly named CTO Daniel Dean, the company offers its Digital Checkup™ platform. The Digital Checkup™ automates delivery of personalized messaging based on a longitudinal patient profile dynamically derived from EHRs, biometric devices and self-reported data. Conversa aims to enhance the physician–patient relationship through continuous, collaborative, structured communications between visits. The company closed a $2.5M seed funding round and intends to use the proceeds to expand its Digital Checkup service with distribution partners in care management, population health and customer relationship management.

No current team members are available.